Form 8-K - Current report:
SEC Accession No. 0001193125-21-264582
Filing Date
2021-09-02
Accepted
2021-09-02 17:00:59
Documents
12
Period of Report
2021-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d206699d8k.htm   iXBRL 8-K 22523
  Complete submission text file 0001193125-21-264582.txt   144364

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20210830.xsd EX-101.SCH 2903
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20210830_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20210830_pre.xml EX-101.PRE 11415
5 EXTRACTED XBRL INSTANCE DOCUMENT d206699d8k_htm.xml XML 3413
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 211234028
SIC: 2834 Pharmaceutical Preparations